Medine.co.uk

Bezalip Retard Tablets

Document: spc-doc_PLPI 04423-0334 change

Product Summary

1.    Trade Name of the Medicinal Product Not applicable.

2.    Qualitative and Quantitative Composition

Not applicable.

3.    Pharmaceutical Form

Not applicable.

Clinical Particulars

4.1.    Therap euti c Indi cati ons Not applicable.

4.2.    Posology and Method of Administration

Not applicable.

4.3.    Contra-indications

Not applicable.

4.4. Special Warnings and Precautions for Use

Not applicable.

4.5. Interactions with other Medicaments and other forms of Interaction


4.6.    Pregnancy and Lactation

Not applicable.

4.7.    Effects on Ability to Drive and Use Machines

Not applicable.

4.8.    Undesirable Effects

Not applicable.

4.9.    Overdose

Not applicable.

Pharmacological Properties

5.1.    Pharmacodynamic Properties Not applicable.

5.2.    Pharmacokinetic Properties

Not applicable.

5.3.    Preclinical Safety Data

Not applicable.

Pharmaceutical Particulars

6.1.    List of Excipients Not applicable.

6.2.    Incompatibilities

Not applicable.

6.3.    Shelf Life

Not applicable.

6.4.    Special Precautions for Storage

Not applicable.

6.5.    Nature and Contents of Container

Not applicable.

6.6.    Instruction for Use/Handling Not applicable.

Administrative Data

7.    Marketing Authorisation Holder Not applicable.

8.    Marketing Authorization Number

Date of First Authorisation/Renewal of Authorisation

9.


Not applicable.

10.


Date of (Partial) Revision of the Text

Not applicable.